ITGB1 and clear cell renal carcinoma: The effect of LOXL2 on upregulating ITGB1 expression via inhibiting degradation of ITGB1 protein by proteasome pathway has been reported in clear cell renal cell carcinoma [43], however the authors did not do any further studies to investigate the interactions of the two proteins.